Measuring the physical properties of individual cells in body fluids can diagnose cancer with a high degree of accuracy, and could reduce the need for more cumbersome diagnostic procedures.
For the first time, researchers have shown the predictive power of a group of overlooked lymph nodes that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma.
A molecule has been discovered that could lead to noninvasive detection and treatment of lung cancer.
A phase II study is the first to show that adding two targeted therapy drugs to the standard chemotherapy regimen is safe and effective as first-line treatment of advanced non-small cell lung cancer.
The investigational drug PF-06463922 has the potential to become a new treatment option for patients who have lung cancer that harbors abnormalities in the ALK gene.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|